男性尿失禁市场：按失禁类型、按产品类型、按用途类型、按最终用户医院、按分销管道、按地区

男性尿失禁市场规模预计在 2025 年达到 68.2 亿美元，预计到 2032 年将达到 101.9 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 5.9%。

全球男性尿失禁市场是医疗保健产业的重要组成部分，致力于解决一种经常被低估、影响全球数百万男性的疾病。男性尿失禁的特征是膀胱不自主地失去控制，其表现形式多种多样，包括压力性尿失禁、急性尿失禁、充盈性尿失禁和混合性尿失禁，每种类型都有其独特的临床挑战和治疗要求。此疾病主要影响老年男性，且盛行率老龄化增加而显着增加，但由于摄护腺手术、神经病变和创伤等因素，年轻男性也可能受到影响。

该市场涵盖了一系列全面的治疗方案，包括吸收产品、外部导管、植入式装置、药物干预和外科手术，旨在管理或治疗失禁的根本原因。儘管男性尿失禁对生活品质、社会功能和心理健康有重大影响，但它仍然被视为一种耻辱，导致患者诊断不足，并延误就医。

市场动态

全球男性尿失禁市场主要由几个相互关联的因素所驱动，这些因素共同推动了该治疗领域的市场扩张和技术创新。全球人口老化是最重要的市场驱动力，尿失禁的盛行率随着年龄的增长而显着增加，尤其是在 65 岁及以上的男性中，导致需要管理解决方案的患者数量不断增加。医疗保健组织和倡导团体进行的宣传活动和教育倡议正在逐渐减少围绕男性尿失禁的耻辱感，鼓励更多男性寻求专家帮助并选择适当的治疗方法。医疗设备技术的进步，包括先进的人工尿道括约肌、男性用吊带和微创手术技术的发展，正在扩大治疗可能性并改善患者的预后。

此外，摄护腺相关疾病（例如良性摄护腺增生和摄护腺癌）的盛行率不断上升，这些疾病需要手术干预，直接导致男性尿失禁的发生率上升，增加了对预防和治疗解决方案的需求。然而，市场成长面临重大限制因素，例如与疾病相关的持续存在的社会耻辱感和尴尬感，导致漏报和诊断延误，从而限制了市场渗透。高昂的治疗费用，尤其是先进的外科手术和植入式医疗设备，构成了获得治疗的重大障碍，尤其是在医疗基础设施和保险覆盖有限的发展中地区。围绕医疗设备核准和监管干预的监管复杂性，延迟了产品的上市，并增加了製造商的开发成本。新兴市场蕴藏着巨大的机会，医疗基础设施的改善和医疗支出的增加为市场扩张开闢了新的途径。正在进行的再生医学和生物工程解决方案等新型治疗方法的研究有望改变治疗模式并挖掘尚未开发的市场潜力。

本次调查的主要特点

• 本报告对全球男性尿失禁市场进行了详细分析，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
• 它还强调了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，对全球男性尿失禁市场的主要企业进行了概述。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
• 全球男性尿失禁市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过全球男性尿失禁市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球男性尿失禁市场（按失禁类型）

• 介绍
• 应力性尿失禁
• 急性尿失禁
• 充溢性尿失禁
• 功能性尿失禁
• 混合性尿失禁（压力性+急迫性）

5. 2020-2032 年全球男性尿失禁市场（依产品类型）

• 介绍
• 吸收性产品
• 垫片和护具
• 外导管（尿道鞘套）
• 乳胶鞘套
• 内部导管
• 留置导尿管（Foley导尿管）
• 间歇导尿管
• 其他设备和系统
• 男性用吊带

6. 2020-2032 年全球男性尿失禁市场（依年龄层划分）

• 介绍
• 18至39岁
• 40至59岁
• 60至74岁
• 75岁或以上

7. 全球男性尿失禁市场（依使用类型），2020-2032 年

• 介绍
• 可重复使用的
• 一次性的

8. 全球男性尿失禁市场（依最终用户划分），2020-2032 年

• 介绍
• 医院
• 泌尿系统诊所
• 家庭医疗保健环境
• 长期照护中心/疗养院
• 门诊手术中心
• 其他的

9. 2020-2032 年全球男性尿失禁市场（依分销管道）

• 介绍
• 离线
• 在线的

10. 2020-2032 年全球男性尿失禁市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争格局

• Coloplast A/S
• ConvaTec Group PLC
• Hollister Incorporated
• Kimberly-Clark Corporation
• Medtronic PLC
• Boston Scientific Corporation
• Braun Melsungen AG
• Teleflex Incorporated
• Wellspect HealthCare
• Procter and Gamble Co.
• AbbVie Inc.
• Pfizer Inc.
• Laboratoires URGO
• Ontex Healthcare
• R. Bard（BD）

第 12 章分析师建议

• 机会
• 一致的机会地图

第十三章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Male Urinary Incontinence Market is estimated to be valued at USD 6.82 Bn in 2025 and is expected to reach USD 10.19 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

The global male urinary incontinence market represents a critical segment within the broader healthcare industry, addressing a prevalent yet often underreported condition affecting millions of men worldwide. Male urinary incontinence, characterized by the involuntary loss of bladder control, encompasses various types including stress incontinence, urge incontinence, overflow incontinence, and mixed incontinence, each presenting unique clinical challenges and treatment requirements. This condition predominantly affects older men, with prevalence rates increasing significantly with age, though it can also impact younger individuals due to factors such as prostate surgery, neurological disorders, or traumatic injuries.

The market encompasses a comprehensive range of therapeutic solutions including absorbent products, external catheters, implantable devices, pharmaceutical interventions, and surgical procedures designed to manage or treat the underlying causes of incontinence. Despite the significant impact on quality of life, social functioning, and psychological well-being, male urinary incontinence remains stigmatized, leading to underdiagnosis and delayed treatment seeking behavior among affected individuals, which consequently influences market dynamics and growth patterns across different geographical regions.

Market Dynamics

The global male urinary incontinence market is primarily driven by several interconnected factors that collectively propel market expansion and innovation within this therapeutic area. The aging global population serves as the most significant market driver, as the prevalence of urinary incontinence increases substantially with age, particularly among men over 65 years, creating a growing patient pool requiring management solutions. Rising awareness campaigns and educational initiatives by healthcare organizations and advocacy groups are gradually reducing the stigma associated with male incontinence, encouraging more men to seek professional medical help and appropriate treatment options. Technological advancements in medical devices, including the development of sophisticated artificial urinary sphincters, male slings, and minimally invasive surgical techniques, are expanding treatment possibilities and improving patient outcomes.

Additionally, the increasing prevalence of prostate-related disorders, including benign prostatic hyperplasia and prostate cancer requiring surgical intervention, directly contributes to the incidence of male urinary incontinence, thereby driving demand for both preventive and therapeutic solutions. However, market growth faces significant restraints including persistent social stigma and embarrassment associated with the condition, leading to underreporting and delayed diagnosis, which limits market penetration. High treatment costs, particularly for advanced surgical procedures and implantable devices, pose substantial barriers to access, especially in developing regions with limited healthcare infrastructure and insurance coverage. Regulatory complexities surrounding medical device approvals and pharmaceutical interventions can delay product launches and increase development costs for manufacturers. Nevertheless, substantial opportunities exist within emerging markets where improving healthcare infrastructure and increasing healthcare expenditure create new avenues for market expansion, while ongoing research into novel therapeutic approaches, including regenerative medicine and bioengineered solutions, promises to revolutionize treatment paradigms and capture untapped market potential.

Key Features of the Study

• This report provides an in-depth analysis of the global male urinary incontinence market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global male urinary incontinence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Wellspect HealthCare, Procter and Gamble Co., AbbVie Inc., Pfizer Inc., Laboratoires URGO, Ontex Healthcare, and C. R. Bard (BD).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global male urinary incontinence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global male urinary incontinence market.

Market Segmentation

• Type of Incontinence Insights (Revenue, USD Bn, 2020 - 2032)
  • Stress Urinary Incontinence
  • Urge Urinary Incontinence
  • Overflow Urinary Incontinence
  • Functional Urinary Incontinence
  • Mixed Incontinence (Stress + Urge)
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Absorbent Products
  • Pads and Guards
  • Adult Diapers
  • Protective Underwear
  • Bed Protectors and Mattress Covers
  • External Catheters (Urinary Sheaths)
  • Latex Sheaths
  • Silicone Sheaths
  • Hydrocolloid Sheaths
  • Internal Catheters
  • Indwelling (Foley) Catheters
  • Intermittent Catheters
  • Other Devices and Systems
  • Male Slings
  • Artificial Urinary Sphincters
  • Electrical Stimulation Devices/Penile Clamps
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • 18-39 Years
  • 40-59 Year
  • 60-74 Years
  • 75 Years and Above
• Usage Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Reusable
  • Disposable
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Urology Clinics
  • Home Healthcare Settings
  • Long-Term Care Centers / Nursing Homes
  • Ambulatory Surgical Centers
  • Others
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Offline
  • Online
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Coloplast A/S
  • ConvaTec Group PLC
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • Teleflex Incorporated
  • Wellspect HealthCare
  • Procter and Gamble Co.
  • AbbVie Inc.
  • Pfizer Inc.
  • Laboratoires URGO
  • Ontex Healthcare
  • R. Bard (BD)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Male Urinary Incontinence Market, By Type of Incontinence
  • Global Male Urinary Incontinence Market, By Product Type
  • Global Male Urinary Incontinence Market, By Age Group
  • Global Male Urinary Incontinence Market, By Usage Type
  • Global Male Urinary Incontinence Market, By End User
  • Global Male Urinary Incontinence Market, By Distribution Channel

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Male Urinary Incontinence Market, By Type of Incontinence, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Stress Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urge Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Overflow Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Functional Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mixed Incontinence (Stress + Urge)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Male Urinary Incontinence Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Absorbent Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pads and Guards
  • Adult Diapers
  • Protective Underwear
  • Bed Protectors and Mattress Covers
• External Catheters (Urinary Sheaths)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Latex Sheaths
  • Silicone Sheaths
  • Hydrocolloid Sheaths
• Internal Catheters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Indwelling (Foley) Catheters
• Intermittent Catheters
• Other Devices and Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Male Slings
  • Artificial Urinary Sphincters
  • Electrical Stimulation Devices/Penile Clamps

6. Global Male Urinary Incontinence Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 18-39 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 40-59 Year
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 60-74 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 75 Years and Above
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Male Urinary Incontinence Market, By Usage Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Reusable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Disposable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Male Urinary Incontinence Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Healthcare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Long-Term Care Centers / Nursing Homes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Male Urinary Incontinence Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Offline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Male Urinary Incontinence Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Sub-region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Coloplast A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ConvaTec Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hollister Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kimberly-Clark Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Wellspect HealthCare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Procter and Gamble Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratoires URGO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ontex Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• R. Bard (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us